Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b-Reference-Cited by-同舟云学术

Treatment of thrombocytosis in chronic myeloproliferative disorders with interferon alfa-2b

Published:1991-12 Issue: Volume:27 Page:S58-S63
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Seewann Heinz L.,Zikulnig Ronald,Gallhofer Gertraud,Schmid Christine

Publisher

Elsevier BV

Subject

Oncology

Reference23 articles.

1. Essential thrombocythaemia;Tobelem;Baillière's Clin Haematol,1989

2. Chronic myeloproliferative disease (CMPD) with thrombocytosis: how accurate is clinical diagnosis of megakaryocytic granulocytic myelosis (CMGM);Seewann;Blut,1988

3. Therapeutic recommendations in polycythemia vera based on Polycythemia Study Group protocols;Berk;Semin Hematol,1986

4. Anagrelide: a new drug for treating thrombocytosis;Silverstein;N Engl J Med,1988

5. Inhibitory effects of interferon on mouse megakaryocytic progenitor cells in culture;Dukes;Exp Hematol,1980

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in the treatment of polycythemia vera;Leukemia & Lymphoma;2022-04-07

2. Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis;Leukemia;2020-09-01

3. Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review;International Journal of Molecular Sciences;2020-05-30

4. A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms;Expert Review of Hematology;2011-12

5. Interferon-α therapy in bcr-abl-negative myeloproliferative neoplasms;Leukemia;2008-10-09